CEN/TS 17981-1:2023, In vitro diagnostic Next Generation Sequencing (NGS) workflows — Part 1: Human DNA examination CEN/TS 17981-2:2023, In vitro diagnostic Next Generation Sequencing (NGS) workflows — Part 2: Human RNA examination These 2 CEN/TS documents,

High-level Conference: Tackling the implementation gap for the uptake of NGS and advanced molecular diagnostics into healthcare systems: The Role of Pathology and Medical Laboratories Organised as an ECP satellite event by

The Instand NGS4P project consortium and Contractors will meet in Graz on the 9th of April 2024 to present the project and the developed Solutions at a public meeting. Two keynote speakers,

The canSERV Consortium announces its first Challenge-Call on "Advancing Personalised Oncology".Cancer Researchers in, and outside the EU are invited to apply for free access to cutting-edge transnational services with an indicative overall

This year's meeting of the Instand NGS4P project consortium and contractors was held in Vienna, Austria, as a hybrid meeting combining both face-to-face and online formats. The two-day event provided a valuable

Instand-NGS4P Beneficiary, OECI - the Organisation of European Cancer Institutes - has dedicated an entire Newsletter to the Instand-NGS4P project. The Newsletter describes the aims of the project, and progress made to

This workshop addresses the key issues facing genomic research such as ethical and legal issues, privacy and data protection, data standardisation and implementation of standardised sample workflows. For further information on this

We are delighted to announce that 11 of the 14 Contractors who completed Phase 1 have been selected to enter Phase 2 and were awarded contracts on the 15th of November 2022

Analysis carried out by Instand-NGS4P´s WP7 of existing gaps in current standardization led to the proposal of 2 new Work Items for development in partnership with CEN/TC 140 “In vitro diagnostic medical